合成路线1
该中间体在本合成路线中的序号:
(I)
【1】
Yang N, DOng JJ, Liu KI,et a1.2005.Synthe^18 0f bosentan as an end.thelin receptor antngonisL中国药物化学杂志,15 (4): 230~233 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
61569 |
dimethyl 2-(2-methoxyphenoxy)malonate
|
|
C12H14O6 |
详情 |
详情
|
(III) |
66160 |
pyrimidine-2-carboximidamide hydrochloride |
|
C5H7ClBN4 |
详情 | 详情
|
(IV) |
50370 |
5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4,6(1H,5H)-pyrimidinedione
|
|
C15H12N4O4 |
详情 |
详情
|
(V) |
41585 |
|
|
C15H10Cl2N4O2 |
详情 |
详情
|
(VI) |
50371 |
4-(tert-Butyl)benzenesulphonamide
|
|
C10H15NO2S |
详情 |
详情
|
(VII) |
50372 |
|
|
C25H24ClN5O4S |
详情 |
详情
|
(VIII) |
50374 |
|
|
C31H37N5O6S |
详情 |
详情
|
(IX) |
50375 |
|
|
C28H29N5O7S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) By esterification of guaiacol (II) with 4-isobutylhydratropoyl chloride (I) by means of H2SO4.
【1】
Baiochi, L.; Silvestrini, B.; Proceso para la preparacion de p-isobutil-hidratropato de guayacol. ES 464502 .
|
【2】
Baiochi, L.; Silvestrini, B. (ACRAF SpA); Guaiacol p-isobutyl hydratropate. DE 2726435; FR 2357526; GB 1538636; JP 53025536; US 4134989 .
|
【3】
Blancafort, P.; Castaner, J.; de Angelis, L.; Serradell, M.N.; AF-2259. Drugs Fut 1980, 5, 11, 539.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32706 |
2-(3-isobutylphenyl)propanoyl chloride
|
|
C13H17ClO |
详情 |
详情
|
(II) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The condensation of 2-methoxyphenol (I) with ethylene oxide (II) gives 2-(2-methoxyphenoxy)ethanol (III), which is treated with SOCl2 to yield 2-(2-methoxyphenoxy)ethyl chloride (IV). The reaction of (IV) with benzylamine (A) gives N-[2-(2-methoxyphenoxy)ethyl]benzylamine (V), which is condensed with 2-methyl-5-bromoacetylbenzenesulfonamide (VI) affording N-[2-(2-methoxyphenoxy)ethyl]-N-[(4-methyl-3-aminosulfonylbenzoyl)methyl]benzylamine (VII). The reduction of (VII) with NaBH4 affords the corresponding protected carbinol (VIII), which is finally debenzylated by hydrogenation with H2 over Pd/C.
【1】
Arima, H.; Tamazawa, K.; Synthesis of 14C-labeled 5-[1-hydroxy-2-[2-(o-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzenesulfonamide hydochloride (YM-09538). J Label Compd Radiopharm 1983, 20, 7, 803-811.
|
【2】
Fujikura, T.; et al. (Yamanouchi Pharmaceutical Co., Ltd.); Phenylethanolamine derivatives. DE 2843016; ES 474149; ES 481549; FR 2405931; GB 2006772 .
|
【3】
Serradell, M.N.; Blancafort, P.; Castaner, J.; Leeson, P.A.; Mealy, N.E.; YM-09,538. Drugs Fut 1981, 6, 7, 425.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
10393 |
Oxirane; Ethylene oxide
|
75-21-8 |
C2H4O |
详情 | 详情
|
(III) |
30526 |
2-(2-methoxyphenoxy)-1-ethanol
|
|
C9H12O3 |
详情 |
详情
|
(IV) |
30527 |
2-(2-chloroethoxy)phenyl methyl ether; 1-(2-chloroethoxy)-2-methoxybenzene
|
|
C9H11ClO2 |
详情 |
详情
|
(V) |
30528 |
N-benzyl-2-(2-methoxyphenoxy)-1-ethanamine; N-benzyl-N-[2-(2-methoxyphenoxy)ethyl]amine
|
|
C16H19NO2 |
详情 |
详情
|
(VI) |
30529 |
5-(2-bromoacetyl)-2-methylbenzenesulfonamide
|
|
C9H10BrNO3S |
详情 |
详情
|
(VII) |
30530 |
5-(2-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]acetyl)-2-methylbenzenesulfonamide
|
|
C25H28N2O5S |
详情 |
详情
|
(VIII) |
30531 |
5-(2-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-1-hydroxyethyl)-2-methylbenzenesulfonamide
|
|
C25H30N2O5S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(III) Acetylsalicylic acid (I) was converted to acid chloride (II) by refluxing in a SOCl2 solution. Condensation of acid chloride (II) with guaiacol (III) either in the absence or in the presence of tertiary amines gave rise to the target orthoester derivative. Alternatively, the title compound has been prepared by treatment of acetylsalicylic acid (I) with several acid anhydrides, followed by guaiacol (III).
【1】
Hundewadt, M.; Senning, A.; Aspirin prodrugs: 2-Methyl-2-aryloxy-4H-1,3-benzodioxin-4-ones acting as true aspirin prodrugs. Acta Chem Scand 1990, 44, 7, 746.
|
【2】
Quadro, G. (Dr. Lo. Zambeletti SpA); 2,4-Dioxacyclohexanone deriv.. BE 0890731; US 4358444 .
|
【3】
Beck, C.; Preparation of 3-methyl-3-(O-methoxyphenoxy)benzo-2,4-dioxacycloheanone. GB 2101127 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16899 |
2-(Acetoxy)benzoic acid; Aspirin; Acetylsalicylic acid
|
50-78-2 |
C9H8O4 |
详情 | 详情
|
(II) |
16900 |
2-(chlorocarbonyl)phenyl acetate; Acetylsalicyloyl chloride
|
5538-51-2 |
C9H7ClO3 |
详情 | 详情
|
(III) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) The condensation of 2-methoxyphenol (I) with 2-bromoethanal dimethylacetal (II) by means of K2CO3 in hot DMF gives 2-(2-methoxyphenoxy)ethanal dimethylacetal (III), which is hydrolyzed to the corresponding free aldehyde (IV) with 2N H2SO4 in methanol. The cyclization of (IV) with cysteamine (V) by means of potassium acetate in water affords 2-(2-methoxyphenoxymethyl)thiazolidine (VI), which is finally condensed with ethoxymalonyl chloride (VII) by means of KHCO3 in ethyl acetate.
【1】
Gandolfi, C.A.; Spinelli, S.; Tofanetti, O.; Russo, R.; Tognella, S. (Boehringer Ingelheim Italia SpA); Antitussive and mucus regulating 2-substituted thiazolidines. AU 8545242; EP 0169581; ES 8605249; GB 2164333; GB 2177690; JP 1986063669; US 4857643 . |
【2】
Gandolfi, C.A.; Di Domenico, R.; Spinelli, S.; Lumachi, B.; Gallico, L.; Tognella, S. (Boehringer Ingelheim Italia SpA); Beta-carbonyl-carboxyamides of 1,3-thiazolidines. EP 0333080; JP 1991504123; US 5206254 .
|
【3】
De Angelis, L.; Moguisteine. Drugs Fut 1991, 16, 7, 618.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
13183 |
2-Bromo-1,1-dimethoxyethane; 2-Bromo-1-methoxyethyl methyl ether; Bromoacetaldehyde dimethyl acetal
|
7252-83-7 |
C4H9BrO2 |
详情 | 详情
|
(III) |
13184 |
1-(2,2-Dimethoxyethoxy)-2-methoxybenzene; 2-(2,2-Dimethoxyethoxy)phenyl methyl ether
|
|
C11H16O4 |
详情 |
详情
|
(IV) |
13185 |
2-(2-Methoxyphenoxy)acetaldehyde
|
|
C9H10O3 |
详情 |
详情
|
(V) |
13186 |
2-Aminoethanethiol; 2-Amino-1-ethanethiol; 2-Aminoethylhydrosulfide; Cysteamine
|
60-23-1 |
C2H7NS |
详情 | 详情
|
(VI) |
13187 |
2-[(2-Methoxyphenoxy)methyl]-1,3-thiazolidine; 2-Methoxyphenyl 1,3-thiazolidin-2-ylmethyl ether
|
|
C11H15NO2S |
详情 |
详情
|
(VII) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) The condensation of 1-methyl-5-(4-methylbenzoyl)pyrrole-2-acetic acid (I) with glycine ethyl ester (II) by means of carbonyldiimidazole (CDI) and triethylamine in THF gives the corresponding acetamidoacetate (III), which is hydrolyzed with NaOH in THF-water yielding 2-[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetamido]acetic acid (IV). Finally, this compound is esterified with 2-methoxyphenol (guayacol) (V) by means of CDI in hot THF.
【1】
Baglioni, A. (Medosan; Sigma-Tau); Pyrroleacetic acid amides, their preparation and use. BE 0896018 .
|
【2】
Serradell, M.N.; Castaner, J.; Castaner, R.M.; Arrigoni-Martelli, E.; ST-679. Drugs Fut 1989, 14, 10, 963.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11352 |
2-[1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid
|
|
C15H15NO3 |
详情 |
详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
21363 |
ethyl 2-([2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl]amino)acetate
|
|
C19H22N2O4 |
详情 |
详情
|
(IV) |
21364 |
2-([2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl]amino)acetic acid
|
|
C17H18N2O4 |
详情 |
详情
|
(V) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(VI) The conversion of 2-chloropyrimidine (I) to pyrimidine-2-carboxamidine (III) is performed by known methods through the intermediate pyrimidine-2-carbonitrile (II). The cyclization of (III) with 2-(2-methoxyphenoxy)malonic acid diethyl ester (IV) -prepared by condensation of 2-chloromalonic acid diethyl ester (V) with guaiacol (VI)- yields the bipyrimidinedione (VII). This compound is treated with refluxing POCl3 to afford the dichlorobipyrimidine (VIII). The chlorine monosubstitution in (VIII) with 4-tert-butylphenylsulfonamide (IX), K2CO3 and tetrabutylammonium bromide (TBAB) in toluene provides the substituted sulfonamide (X), which is submitted to a second chlorine substitution with ethyleneglycol mono-tert-butyl ether (XI) by means of NaOH in hot toluene to give the tert-butyl-intermediate (XII). Finally, this compound is deprotected by reaction with formic acid yielding the formate ester (XIII), which is hydrolyzed with NaOH in ethanol/water, and submitted to crystallization in refluxing ethanol/water to afford the target bosentan.
【1】
Harrington, P.J.; Khatri, H.N.; DeHoff, B.S.; Guinn, M.R.; Boehler, M.A.; Glaser, K.A.; Research and development of a second-generation process for bosentan, and endothelin receptor antagonist. Org. Proc. Res. & Develop. 2002, 6, 2, 120.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11191 |
2-Chloropyrimidine
|
1722-12-9 |
C4H3ClN2 |
详情 | 详情
|
(II) |
61568 |
2-Pyrimidinecarbonitrile; 2-Cyanopyrimidine
|
14080-23-0 |
C5H3N3 |
详情 | 详情
|
(III) |
50368 |
2-pyrimidinecarboximidamide
|
|
C5H6N4 |
详情 |
详情
|
(IV) |
61569 |
dimethyl 2-(2-methoxyphenoxy)malonate
|
|
C12H14O6 |
详情 |
详情
|
(V) |
59503 |
dimethyl chloromalonate
|
28868-76-0 |
C5H7ClO4 |
详情 | 详情
|
(VI) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(VII) |
50370 |
5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4,6(1H,5H)-pyrimidinedione
|
|
C15H12N4O4 |
详情 |
详情
|
(VIII) |
41585 |
|
|
C15H10Cl2N4O2 |
详情 |
详情
|
(IX) |
50371 |
4-(tert-Butyl)benzenesulphonamide
|
|
C10H15NO2S |
详情 |
详情
|
(X) |
50372 |
|
|
C25H24ClN5O4S |
详情 |
详情
|
(XI) |
50373 |
2-tert-Butoxyethanol; Ethylene glycol mono-tert-butyl ester
|
7580-85-0 |
C6H14O2 |
详情 | 详情
|
(XII) |
50374 |
|
|
C31H37N5O6S |
详情 |
详情
|
(XIII) |
50375 |
|
|
C28H29N5O7S |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(XVIII) The bromination of 1-acetyl-5-propionylindoline (I) with pyrrolidone hydrotribromide (PTBr) and sulfuric acid in THF gives the alpha-bromo derivative (II), which is reduced with triethylsilane in TFA yielding the 2-bromopropyl compound (III). Nitration of (III) with HNO3 in HOAc affords the 7-nitroindoline (IV), which is reduced to the corresponding amine derivative (V) with H2 over PtO2 in ethanol. The reaction of amine (V) with NaNO2/HCl, followed by treatment with CuCN, provides 1-acetyl-5-(2-bromopropyl)indoline-7-carbonitrile (VI), which is treated with NaN3 in hot ethylene glycol monomethyl ether/water to yield the 2-azidopropyl derivative (VII). Reduction of (VII) with H2 over Pd/BaSO4 in ethanol affords the expected 2-aminopropyl compound (VIII), which is condensed with 2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl bromide (IX) by means of NaHCO3 in ethanol to provide the secondary amine (X).
The intermediate 2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl bromide (IX) has been obtained as follows: Alkylation of 2-methoxyphenol (XVIII) with 2,2,2-trifluoroethyl iodide (XIX) by means of K2CO3 in hot DMF gives 1-methoxy-2-(2,2,2-trifluoroethoxy)benzene (XX), which is demethylated by means of BBr3 in dichloromethane to yield the corresponding phenol (XXI). Finally, this compound is alkylated with 1,2-dibromoethane (XXII) and NaOH in water at 120 C (1,2).
【1】
Sorbera, L.A.; Castaner, J.; Silvestre, J.S.; KMD-3213. Drugs Fut 2001, 26, 6, 553.
|
【2】
Kitazawa, M.; Ban, M.; Okazaki, K.; Ozawa, M.; Yazaki, T.; Yamagishi, R. (Kissei Pharmaceutical Co., Ltd.); Indoline cpds. for the treatment of dysuria. EP 0600675; JP 1994220015; US 5387603 .
|
【3】
Kitazawa, M.; Ozawa, M.; Okazaki, K.; Yamagishi, R.; Yazaki, T.; Saka, M. (Kissei Pharmaceutical Co., Ltd.); Indole derivs.. JP 1995330726 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47548 |
1-(1-acetyl-2,3-dihydro-1H-indol-5-yl)-1-propanone
|
|
C13H15NO2 |
详情 |
详情
|
(II) |
47549 |
1-(1-acetyl-2,3-dihydro-1H-indol-5-yl)-2-bromo-1-propanone
|
|
C13H14BrNO2 |
详情 |
详情
|
(III) |
47550 |
1-[5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C13H16BrNO |
详情 |
详情
|
(IV) |
47551 |
1-[5-(2-bromopropyl)-7-nitro-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C13H15BrN2O3 |
详情 |
详情
|
(V) |
47552 |
1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C13H17BrN2O |
详情 |
详情
|
(VI) |
47553 |
1-acetyl-5-(2-bromopropyl)-7-indolinecarbonitrile
|
|
C14H15BrN2O |
详情 |
详情
|
(VII) |
47554 |
1-acetyl-5-(2-azidopropyl)-7-indolinecarbonitrile
|
|
C14H15N5O |
详情 |
详情
|
(VIII) |
47555 |
1-acetyl-5-(2-aminopropyl)-7-indolinecarbonitrile
|
|
C14H17N3O |
详情 |
详情
|
(IX) |
47556 |
1-(2-bromoethoxy)-2-(2,2,2-trifluoroethoxy)benzene; 2-(2-bromoethoxy)phenyl 2,2,2-trifluoroethyl ether
|
|
C10H10BrF3O2 |
详情 |
详情
|
(X) |
47557 |
1-acetyl-5-[2-([2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino)propyl]-7-indolinecarbonitrile
|
|
C24H26F3N3O3 |
详情 |
详情
|
(XVIII) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(XIX) |
18806 |
1,1,1-trifluoro-2-iodoethane
|
353-83-3 |
C2H2F3I |
详情 | 详情
|
(XX) |
47558 |
1-methoxy-2-(2,2,2-trifluoroethoxy)benzene; 2-methoxyphenyl 2,2,2-trifluoroethyl ether
|
|
C9H9F3O2 |
详情 |
详情
|
(XXI) |
47559 |
2-(2,2,2-trifluoroethoxy)phenol
|
|
C8H7F3O2 |
详情 |
详情
|
(XXII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(V) The reduction of omega-chloropropiophenone (I) with NaBH4 in ethanol gives 3-chloro-1-phenyl-1-propanol (II), which is treated with butyric anhydride and pyridine in dichloromethane yielding the corresponding racemic ester (III). The optical resolution of (III) with immobilized lipase B from Candida antarctica (CALB) affords a mixture of unreacted (S)-ester and (R)-alcohol (IV) that are separated by column chromatography. The condensation of alcohol (IV) with 2-methoxyphenol (V) by means of PPh3 and diethyl azodicarboxylate (DEAD) in THF gives the corresponding ether (VI), which is finally treated with methylamine in refluxing ethanol.
【1】
Anthonsen, T.; Ho, B.H.; Liu, H.L.; Chemoenzymatic synthesis of the non-tricyclic antidepressants fluoxetine, tomoxetine and nisoxetine. J Chem Soc - Perkins Trans I 2000, 11, 11, 1767.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11021 |
Methanamine; Methylamine
|
74-89-5 |
CH5N |
详情 | 详情
|
(I) |
28073 |
3-chloro-1-phenyl-1-propanone
|
936-59-4 |
C9H9ClO |
详情 | 详情
|
(II) |
28074 |
3-chloro-1-phenyl-1-propanol
|
|
C9H11ClO |
详情 |
详情
|
(III) |
37781 |
3-chloro-1-phenylpropyl butyrate
|
|
C13H17ClO2 |
详情 |
详情
|
(IV) |
37782 |
(1R)-3-chloro-1-phenyl-1-propanol
|
|
C9H11ClO |
详情 |
详情
|
(V) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(VI) |
37783 |
1-[[(1R)-3-chloro-1-phenylpropyl]oxy]-2-methoxybenzene; (1R)-3-chloro-1-phenylpropyl 2-methoxyphenyl ether
|
|
C16H17ClO2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) Coupling of 2-methoxyphenol (I) with 3-fluoronitrobenzene (II) produced the diaryl ether (III). The nitro group of (III) was then reduced by catalytic hydrogenation over Raney-Ni, yielding aniline (IV). Reductive alkylation of (IV) with pyridine-3-carboxaldehyde (V) using NaBH4 furnished the secondary amine (VI). This was finally acylated with 2,2,2-trifluoroethylsulfonyl chloride to produce the title sufonamide.
【1】
Monn, J.A.; Hornback, W.J.; Schoepp, D.D.; Dressman, B.A.; Britton, T.C.; Tizzano, J.P.; Johnson, K.W.; Henry, S.S.; Coleman, D.S.; Jagdmann, G.E.J.; Johnson, M.P.; Large, T.H.; Barda, D.A.; Fichtner, M.W. (Eli Lilly and Company); Potentiators of glutamate receptors. WO 0156990 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
55157 |
1-Fluoro-3-nitrobenzene; 3-Fluoro-1-nitrobenzene; 3-Fluoronitrobenzene; 3-Nitrofluorobenzene; m-Fluoronitrobenzene
|
402-67-5 |
C6H4FNO2 |
详情 | 详情
|
(III) |
55158 |
2-methoxyphenyl 3-nitrophenyl ether; 1-methoxy-2-(3-nitrophenoxy)benzene
|
|
C13H11NO4 |
详情 |
详情
|
(IV) |
55159 |
3-(2-methoxyphenoxy)phenylamine; 3-(2-methoxyphenoxy)aniline
|
|
C13H13NO2 |
详情 |
详情
|
(V) |
12849 |
Nicotinaldehyde; 3-Pyridinecarboxaldehyde
|
500-22-1 |
C6H5NO |
详情 | 详情
|
(VI) |
55160 |
3-(2-methoxyphenoxy)-N-(3-pyridinylmethyl)aniline; N-[3-(2-methoxyphenoxy)phenyl]-N-(3-pyridinylmethyl)amine
|
|
C19H18N2O2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) Guaiacol (I) was alkylated by means of boiling dibromoethane (II) to produce the bromoethyl ether (III). From this, the intermediate amine (VI) was prepared by Gabriel synthesis, via condensation with potassium phthalimide (IV) in hot DMF, followed by hydrazinolysis of the resultant N-substituted phthalimide (V).
【1】
Lin, T.-H.; Chen, I.-J.; Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity. EP 1108710; WO 0005209 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
51402 |
2-(2-Bromoethoxy)methoxybenzene; 1-Bromo-2-(2-methoxyphenoxy)ethane
|
4463-59-6 |
C9H11BrO2 |
详情 | 详情
|
(IV) |
27890 |
Potassium phthalimide
|
1074-82-4 |
C8H4KNO2 |
详情 | 详情
|
(V) |
59617 |
2-[2-(2-methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione
|
|
C17H15NO4 |
详情 |
详情
|
(VI) |
31105 |
2-(2-methoxyphenoxy)ethylamine; 2-(2-methoxyphenoxy)-1-ethanamine
|
1836-62-0 |
C9H13NO2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(I)
【1】
Li SC, Huang HQ, Li ZJ. 2003. Synthesis of a novel antianginal agent Ranolazine. 中国药物化学杂志,13: 283~285 |
【2】
Lu WC, Li YQ, Zhao XG, et aL. 2004. Synthesis of ranolazine中国医药工业杂志,35: 641~642 |
【3】
Wang LS, Feng XY, Zhu HY. 2003. Synthesis of anti-angina drug ranolazine. 广西大学学报,自然科学版,28: 301~303 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(VI) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(V)
【1】
Yan J.2007. Synthesis of ranolazine.中国专利申请公开说明书.CN 1915982 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(III) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II)
【1】
Moen AR, Karstad R.Antfiansen T. 2005. Chemo-enzymatic synthesis of both enantiomers of the anti-anginal drug ranolazine. Biocat Biotransfonn, 23: 45~51 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(III) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
66620 |
1-chloro-3-(2-methoxyphenoxy)propan-2-ol |
|
C10H13ClO3 |
详情 | 详情
|
(V) |
66621 |
1-chloro-3-(2-methoxyphenoxy)propan-2-yl butyrate |
|
C14H19ClO4 |
详情 | 详情
|
(VI) |
66622 |
(R)-1-chloro-3-(2-methoxyphenoxy)propan-2-yl butyrate |
|
C14H19ClO4 |
详情 | 详情
|
(VII) |
66623 |
(R)-1-chloro-3-(2-methoxyphenoxy)propan-2-ol |
|
C10H13ClO3 |
详情 | 详情
|
(VIII) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|